How AIDS Has Changed The Nature Of Research

In his best-selling expose, And the Band Played On (New York, St. Martin's Press, 1987), San Francisco Chronicle reporter Randy Shilts documented how AIDS was largely ignored by the research and funding communities until the disease reached crisis proportions. Today, however, AIDS has become a glamorous field of investigation. Because the United States research establishment has become convinced that proceeding at an accelerated pace might help save lives, the processes of proposal review and d

Written byBarbara Spector
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

James Weinrich, an assistant adjunct professor of psychiatry at the University of California, San Diego, says it is now common knowledge that "if your research can be shown to be AIDS-related, funding can be obtained more easily." Thus, he says, researchers are "recasting pre-existing grant [applications] or moving in an AIDS direction" in an attempt to use the speedup to their best advantage.

While fields like immunology are benefiting from the mobilization for crisis, says a biochemist who asks not to be identified, "there's not enough funding for investigations about sexuality." This is a serious omission, he says, because "you can't understand AIDS without understanding sexuality." The reluctance to fund such studies, the biochemist says, stems from "a strong discrimination against research on sexual orientation"; when an openly gay scientist submits a proposal for a gay-related project, the thinking in the establishment is, " `He's that gay scientist--he's just doing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies